Anti-CCP levels | OR | 95% conf. interval | p | |
---|---|---|---|---|
Low | ||||
CAL | 1.227 | 0.742 | 2.027 | 0.425 |
Gender (ref. female) | 1.267 | 0.385 | 4.166 | 0.697 |
Age | 0.969 | 0.921 | 1.019 | 0.214 |
Tobacco (ref. never) | 1.057 | 0.383 | 2.916 | 0.914 |
Disease activity (ref. remission/low) | 1.115 | 0.403 | 3.084 | 0.834 |
Disease evolution time | 0.956 | 0.883 | 1.036 | 0.277 |
Moderate | ||||
CAL | 1.657 | 1.101 | 2.509 | 0.017 |
Gender (ref. female) | 1.589 | 0.552 | 4.573 | 0.390 |
Age | 0.994 | 0.948 | 1.042 | 0.803 |
Tobacco (ref. never) | 0.807 | 0.310 | 2.102 | 0.661 |
Disease activity (ref. remission/low) | 1.601 | 0.621 | 4.126 | 0.330 |
Disease evolution time | 1.012 | 0.952 | 1.076 | 0.705 |
High | ||||
CAL | 1.593 | 1.017 | 2.482 | 0.043 |
Gender (ref. female) | 0.662 | 0.170 | 2.582 | 0.552 |
Age | 0.971 | 0.923 | 1.021 | 0.243 |
Tobacco (ref. never) | 0.850 | 0.305 | 2.369 | 0.756 |
Disease activity (ref. remission/low) | 2.210 | 0.770 | 6.344 | 0.141 |
Disease evolution time | 1.035 | 0.969 | 1.105 | 0.308 |